Company / Total Assets
Maze Therapeutics, Inc. Total Assets History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$397.1M
FY2025
5-year range
$397.1M / $397.1M
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#160 of 214
Health Care
What the data says
Maze Therapeutics, Inc.'s total assets of $397M is lower than 75% of companies in the Health Care sector (FY2025).
Based on SEC 10-K filings.
$397M in FY2025.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 214This company $397.1M Sector average $7.5B
▼
-94.7% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $397.1M | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026